A rapid vesicle electrokinetic chromatography method for the in vitro prediction of non-specific binding for potential PET ligands

被引:26
作者
Jiang, Zhengjin [1 ]
Reilly, John [1 ]
Everatt, Brian [1 ]
Briard, Emmanuelle [2 ]
机构
[1] Novartis Inst Biomed Res, Horsham RH12 5AB, W Sussex, England
[2] Novartis Inst Biomed Res, CH-4002 Basel, Switzerland
关键词
Vesicle electrokinetic chromatography; Positron emission tomography; Non-specific binding; POSITRON-EMISSION-TOMOGRAPHY; TISSUE DISTRIBUTION; BASIC DRUGS; MEMBRANE; LIPOPHILICITY; PERMEABILITY; SITES; BRAIN; BASES; HPLC;
D O I
10.1016/j.jpba.2010.11.004
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
High non-specific binding (NSB) is one of the most common reasons for candidate failure in potential positron emission tomography (PET) radiotracer development. It is of interest to develop high throughput in vitro methods for predicting non-specific binding prior to radiolabeling, which would help guide radiotracer candidate selection and assist decision making in new radiotracer discovery. We evaluated several electrokinetic chromatographic (EKC) systems to help identify PET ligands with low non-specific binding characteristics by mimicking the ligand-brain tissue interaction. The measured retention factors of tracers in clinical use or terminated candidates within AOT vesicle EKC systems were compared with literature in vitro or in vivo NSB data. We conclude that there is a statistical correlation between the chromatographic retention parameters of tested drugs and their NSB. The AOT vesicle EKC method can provide NSB in vitro trend analysis for a large number of drug candidates early in the novel radiotracer discovery process with minimal resources. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:722 / 729
页数:8
相关论文
共 28 条
[1]  
Ansell G.B., 1973, FORM FUNCTION PHSOPH
[2]   Interaction of basic drugs with lipid bilayers using liposome electrokinetic chromatography [J].
Carrozzino, JM ;
Khaledi, MG .
PHARMACEUTICAL RESEARCH, 2004, 21 (12) :2327-2335
[3]  
Cella C.V., 2004, FENS A, VA059, P4
[4]  
Chan GLY, 1998, J NUCL MED, V39, P792
[5]  
FOWLER JS, 1982, J NUCL MED, V23, P437
[6]   A Biomathematical Modeling Approach to Central Nervous System Radioligand Discovery and Development [J].
Guo, Qi ;
Brady, Michael ;
Gunn, Roger N. .
JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (10) :1715-1723
[7]   A method for rapidly predicting drug tissue distribution using surfactant vesicle electrokinetic chromatography [J].
Jiang, Zhengjin ;
Reilly, John ;
Everatt, Brian .
ELECTROPHORESIS, 2008, 29 (17) :3674-3684
[8]   Pharmaceutical profiling method for lipophilicity and integrity using liquid chromatography-mass spectrometry [J].
Kerns, EH ;
Di, L ;
Petusky, S ;
Kleintop, T ;
Huryn, D ;
McConnell, O ;
Carter, G .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2003, 791 (1-2) :381-388
[9]  
Laruelle Marc, 2003, Mol Imaging Biol, V5, P363, DOI 10.1016/j.mibio.2003.09.009
[10]   PREDICTING DRUG-MEMBRANE INTERACTIONS BY HPLC - STRUCTURAL REQUIREMENTS OF CHROMATOGRAPHIC SURFACES [J].
LIU, HL ;
ONG, SW ;
GLUNZ, L ;
PIDGEON, C .
ANALYTICAL CHEMISTRY, 1995, 67 (19) :3550-3557